Çocuklarda Ventriküler Şant Enfeksiyonlarının Yönetimi ve Cerrahi Yaklaşım
Özet
Hidrosefali tedavisinde kullanılan ventriküler şantlar, enfeksiyon ve mekanik arıza gibi ciddi komplikasyonlara yol açabilen ve yüksek morbidite riski taşıyan cerrahi müdahalelerdir. Şant enfeksiyonları genellikle operasyon sırasındaki kontaminasyondan kaynaklanmakta olup ateş, bulantı ve cerrahi bölgede eritem gibi belirtilerle kendini göstermektedir. Tanı sürecinde kan tetkikleri, BOS analizi ve radyolojik görüntüleme yöntemleri kritik rol oynarken, tedavi süreci genellikle enfekte şantın çıkarılması ve hedefe yönelik antibiyotik sağaltımını içeren multidisipliner bir yaklaşımı gerektirmektedir. Enfeksiyon riskini minimize etmek için cerrahi tekniklerin iyileştirilmesi, operasyon süresinin kısalması ve uygun profilaktik önlemlerin alınması büyük önem taşımaktadır.
Ventricular shunts used in the treatment of hydrocephalus are surgical interventions that can lead to serious complications such as infection and mechanical failure, carrying a significant risk of morbidity. Shunt infections usually result from contamination during the operation and manifest with symptoms like fever, nausea, and erythema at the surgical site. While blood tests, CSF analysis, and radiological imaging play a critical role in the diagnostic process, the treatment protocol typically requires a multidisciplinary approach involving the removal of the infected shunt and targeted antibiotic therapy. To minimize the risk of infection, it is crucial to improve surgical techniques, shorten operation times, and implement appropriate prophylactic measures.
Referanslar
Del Bigio MR. Biological reactions to cerebrospinal fluid shunt devices: a review of the cellular pathology. Neurosurgery. 1998;42(2):319-26.
Barton SE, Campbell JW, Piatt JH. Quality measures for the management of hydrocephalus: concepts, simulations, and preliminary field-testing. Journal of Neurosurgery: Pediatrics. 2013;11(4):392-7.
McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clinical infectious diseases. 2003;36(7):858-62.
Piatt Jr JH, Carlson CV. A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience. Pediatric neurosurgery. 1993;19(5):233-42.
Simon TD, Hall M, Riva-Cambrin J, Albert JE, Jeffries HE, LaFleur B, et al. Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Journal of Neurosurgery: Pediatrics. 2009;4(2):156-65.
Schuhmann MU, Ostrowski KR, Draper EJ, Chu J-W, Ham SD, Sood S, et al. The value of C-reactive protein in the management of shunt infections. Journal of Neurosurgery: Pediatrics. 2005;103(3):223-30.
Simon TD, Butler J, Whitlock KB, Browd SR, Holubkov R, Kestle JR, et al. Risk factors for first cerebrospinal fluid shunt infection: findings from a multi-center prospective cohort study. The Journal of pediatrics. 2014;164(6):1462-8. e2.
Morris A, Low DE. Nosocomial bacterial meningitis, including central nervous system shunt infections. Infectious disease clinics of North America. 1999;13(3):735-50.
Ceylan O, Canpolat M. Bacterial Infections of the Central Nervous System. Türkiye Klinikleri J Pediatr Sci. 2018;14(1):117-26
Biyani N, Grisaru-Soen G, Steinbok P, Sgouros S, Constantini S. Prophylactic antibiotics in pediatric shunt surgery. Child's Nervous System. 2006;22(11):1465-71.
Arts SH, Boogaarts HD, van Lindert EJ. Route of antibiotic prophylaxis for prevention of cerebrospinal fluid‐shunt infection. Cochrane Database of Systematic Reviews. 2019(6).
Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Child's Nervous System. 2006;22(7):692-7.
Bayston R, Lari J. A study of the sources of infection in colonised shunts. Developmental Medicine & Child Neurology. 1974;16:16-22.
Bayston R. Epidemiology, diagnosis, treatment, and prevention of cerebrospinal fluid shunt infections. Neurosurgery clinics of North America. 2001;12(4):703-8, viii.
Tunkel et.al 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis Clinical Infectious Diseases, Volume 64, Issue 6, 15 March 2017, Pages e34–e65.
Yang B, Song Y, Gao P, Bao N. Prevention of infection by antibiotic-impregnated shunts after pediatric hydrocephalus treatment: a single center, retrospective study in China. Clinical neurology and neurosurgery. 2016;151:92-5.
Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clinical infectious diseases. 2004;39(9):1267-84.
Dettenkofer M, Forster D, Ebner W, Gastmeier P, Rüden H, Daschner F. The practice of 1perioperative antibiotic prophylaxis in eight German hospitals. Infection. 2002;30(3):164-7.
Ramanan M, Lipman J, Shorr A, Shankar A. A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections. BMC Infect Dis 2015; 15:3.
